Type: Private
On the web: http://www.immucor.com
Employees: 757
Employee growth: (0.4%)

Immucor makes sure you can feel safe about getting a blood transfusion. The company makes manual and automated analysis equipment used by blood banks, hospitals, and clinical laboratories to test blood prior to transfusions. Its traditional reagents are used to manually test samples for blood type, group matching, and foreign substance detection, while its Galileo, Galileo Echo, and Galileo NEO automated instrumentation systems use traditional and proprietary Capture reagents to perform multiple blood tests at one time. Immucor sells its products primarily in North America, Western Europe, and Japan. Immucor was taken private in 2011 by equity firm TPG Capital for some $1.9 billion.

Key numbers for fiscal year ending May, 2011:
Sales: $333.1M
One year growth: 1.2%
Net income: $89.3M
Income growth: 8.2%

Officers:
Chairman: Joseph E. Rosen
President, CEO, and Director: Gioacchino (Nino) De Chirico
EVP and COO: Geoffrey S. (Geoff) Crouse

Competitors:
Bio-Rad Labs
Ortho-Clinical Diagnostics
QIAGEN

© 2012 Hoover's, Inc. All rights reserved.